For example, phthalate metabolites, such as MiBP and MBzP, have been linked to an increased risk of nephrolithiasis, while MECPP, MEP, and MEHHP have been shown to exacerbate MAFLD through metabolic dysfunction (40, 41). This evidence concerns the gene NMRK2 and nephrolithiasis.